Current issue
Volume 24(1); March 2024
-
Complications of immunotherapy in advanced hepatocellular carcinoma
Young-Gi Song, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
J Liver Cancer. 2024;24(1):9-16.
Review ArticleNovember 29, 2023
-
Intrahepatic cholangiocarcinoma: histological diversity and the role of the pathologist
Mina Komuta
J Liver Cancer. 2024;24(1):17-22.
Review ArticleJanuary 3, 2024
-
Intermediate-stage hepatocellular carcinoma: refining substaging or shifting paradigm?
Bernardo Stefanini, Luca Ielasi, Dante Pio Pallotta, Sofia Penazza, Mariarosaria Marseglia, et al.
J Liver Cancer. 2024;24(1):23-32.
Review ArticleMarch 12, 2024
-
Current perspectives on radiotherapy in hepatocellular carcinoma management: a comprehensive review
Dowook Kim, Jun-Sang Kim
J Liver Cancer. 2024;24(1):33-46.
Review ArticleMarch 25, 2024
-
Multidisciplinary approach for hepatocellular carcinoma patients: current evidence and future perspectives
Joo Hyun Oh, Dong Hyun Sinn
J Liver Cancer. 2024;24(1):47-56.
Review ArticleMarch 25, 2024
-
Advancing Korean nationwide registry for hepatocellular carcinoma: a systematic sampling approach utilizing the Korea Central Cancer Registry database
Bo Hyun Kim, E Hwa Yun, Jeong-Hoon Lee, Geun Hong, Jun Yong Park, et al.
J Liver Cancer. 2024;24(1):57-61.
Review ArticleMarch 26, 2024
-
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
Do Young Kim
J Liver Cancer. 2024;24(1):62-70.
Review ArticleMarch 25, 2024
-
Treatment options for solitary hepatocellular carcinoma ≤5 cm: surgery vs. ablation: a multicenter retrospective study
Kazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, Hidenori Toyoda, Toshifumi Tada, et al.
J Liver Cancer. 2024;24(1):71-80.
Original ArticleNovember 6, 2023
-
Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis
Jeayeon Park, Yun Bin Lee, Yunmi Ko, Youngsu Park, Hyunjae Shin, et al.
J Liver Cancer. 2024;24(1):81-91.
Original ArticleJanuary 19, 2024
-
Additional nodules detected using EOB-MRI in patients with resectable single hepatocellular carcinoma: an implication for active treatment strategy
Na Reum Kim, Seoung Yoon Rho, Jonathan Navarro, Chansik An, Dai Hoon Han, et al.
J Liver Cancer. 2024;24(1):92-101.
Original ArticleFebruary 14, 2024
-
Review ArticleNov 29, 2023
Complications of immunotherapy in advanced hepatocellular carcinoma
Young-Gi Song, Jeong-Ju Yoo, Sang Gyune Kim, et al.
J Liver Cancer. 2024;24(1):9-16.
-
Review ArticleJan 3, 2024
Intrahepatic cholangiocarcinoma: histological diversity and the role of the pathologist
Mina Komuta
J Liver Cancer. 2024;24(1):17-22.
-
Review ArticleMar 12, 2024
Intermediate-stage hepatocellular carcinoma: refining substaging or shifting paradigm?
Bernardo Stefanini, Luca Ielasi, Dante Pio Pallotta, et al.
J Liver Cancer. 2024;24(1):23-32.
-
Review ArticleMar 25, 2024
Current perspectives on radiotherapy in hepatocellular carcinoma management: a comprehensive review
Dowook Kim, Jun-Sang Kim
J Liver Cancer. 2024;24(1):33-46.
-
Review ArticleMar 25, 2024
Multidisciplinary approach for hepatocellular carcinoma patients: current evidence and future perspectives
Joo Hyun Oh, Dong Hyun Sinn
J Liver Cancer. 2024;24(1):47-56.
-
Review ArticleMar 26, 2024
Advancing Korean nationwide registry for hepatocellular carcinoma: a systematic sampling approach utilizing the Korea Central Cancer Registry database
Bo Hyun Kim, E Hwa Yun, Jeong-Hoon Lee, et al.
J Liver Cancer. 2024;24(1):57-61.
Recent Issues
-
Vol.24, No.1,
March 2024
-
Vol.23, No.2,
September 2023
-
Vol.23, No.1,
March 2023
-
Vol.22, No.2,
September 2022
-
Vol.22, No.1,
March 2022
-
Vol.21, No.2,
September 2021
-
Vol.21, No.1,
March 2021
-
Vol.20, No.2,
September 2020
-
Vol.20, No.1,
March 2020
-
Vol.19, No.2,
September 2019
TOP
E-submission
THE KOREAN LIVER CANCER ASSOCIATION
Evolving trends in treatment patterns for hepatocellular carcinoma in Korea from 2008 to 2022: a nationwide population-based study
Ji Won Han, Won Sohn, Gwang Hyeon Choi, et al.
Follow JLC on Twitter